SHOW ME

PRESS
Apr 8, 2021

Lyfebulb and Arena Pharmaceuticals Seek Applicants for the 2021 Imagining Life Without Limits – An Inflammatory Bowel Disease Innovation Challenge

Winning Entry to Receive $25,000 Award NEW YORK, NY, USA – April 8, 2021 – Lyfebulb, a …
PRESS
Mar 24, 2021

Lyfebulb and CSL Behring Announce the Finalists for the 2021 Transplant Innovation Challenge

Finalists will compete for a $25,000 award NEW YORK, NY and KING OF PRUSSIA, PA, USA – …
PRESS
Mar 11, 2021

Lyfebulb Announces the Winner of the 2021 Innovation Challenge in Multiple Sclerosis

Evolution Devices has been awarded the $25,000 Innovation Award for its smart stimulation therapy to improve the …
PRESS
Feb 9, 2021

Lyfebulb Announces the Finalists for the 2021 MS Innovation Challenge

Ten patient entrepreneurs have been shortlisted as finalists in the Lyfebulb “Addressing Unmet Needs in MS: An …
PRESS
Feb 8, 2021

Lyfebulb Initiative to Help Organ Transplant Recipients Access Innovative Solutions to Improve Daily Lives

Winner of Innovation Challenge to Receive $25,000 Grant NEW YORK, NY, USA – February 8, 2021 – …
PRESS
Feb 3, 2021

Lyfebulb and TRIO Announce Partnership on Digital Engagement Platform for Transplant Community

NEW YORK, Feb. 3, 2021 — Patient empowerment platform, Lyfebulb, and TRIO (Transplant Recipients International Organization) announced today their partnership …
PRESS
Jan 8, 2021

Lyfebulb Announces Call-to-Action for Submissions to the 2021 Innovation Challenge: Thriving with Transplantation

Winning Entry to Receive $25,000 Grant NEW YORK, NY, USA – January 7, 2021 – Lyfebulb, a …
PRESS
Nov 2, 2020

Lyfebulb Addresses Unmet Needs in Multiple Sclerosis through Patient-Driven Innovation

Applications for the $25,000 Innovation Challenge award now being accepted NEW YORK – (November 2, 2020) – …
PRESS
Oct 27, 2020

Lyfebulb and UnitedHealth Group Announce an Innovation Challenge for Patient Entrepreneurs with Inflammatory Bowel Disease

MINNETONKA, Minn., and NEW YORK (April 23, 2018) Lyfebulb LLC and UnitedHealth Group (NYSE: UNH) invite patient …
PRESS
Aug 13, 2020

Lyfebulb and Helsinn Announce the Winners of the Third Annual Lyfebulb-Helsinn Cancer Innovation Summit & Award

Lyfebulb and Helsinn Announce the Winners of the Third Annual Lyfebulb-Helsinn Cancer Innovation Summit & Award MONACO, …
PRESS

Orexo and Lyfebulb Announce Call for Digital Solutions to Treat Substance Use Disorder

Winning Entry to Receive $25,000 Grant UPPSALA, SWEDEN, AND NEW YORK, NY, USA, June 17th, 2020: Orexo, …
PRESS
Aug 12, 2020

Lyfebulb Seeks Companies with Solutions to Address Substance Use Disorders for an Innovation Challenge

Winning Finalist to Receive $25,000 Grant NEW YORK, NY, USA, July 15, 2020: Lyfebulb, a patient empowerment …